Platforms for production of protein-based vaccines: from classical to next-generation strategies

R Cid, J Bolívar - Biomolecules, 2021 - mdpi.com
To date, vaccination has become one of the most effective strategies to control and reduce
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …

Current state and challenges in developing oral vaccines

JEV Ramirez, LA Sharpe, NA Peppas - Advanced drug delivery reviews, 2017 - Elsevier
While vaccination remains the most cost effective strategy for disease prevention,
communicable diseases persist as the second leading cause of death worldwide. There is a …

Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice

S Raghavan, M Fredriksson… - Clinical & …, 2003 - academic.oup.com
Helicobacter pylori induces symptomatic chronic gastritis in a subpopulation of infected
individuals. The mechanism (s) determining the development and severity of pathology …

Helicobacter pylori Reinfection Is Common in Peruvian Adults after Antibiotic Eradication Therapy

G Soto, CT Bautista, DE Roth, RH Gilman… - The Journal of …, 2003 - academic.oup.com
To characterize posttreatment recurrence of Helicobacter pylori in Peru, 192 adults with H.
pylori–positive gastric biopsy specimens were monitored by 14C-Urea breath test, after …

HpaA Is Essential for Helicobacter pylori Colonization in Mice

E Carlsohn, J Nyström, I Bölin, CL Nilsson… - Infection and …, 2006 - Am Soc Microbiol
Infection with the human gastric pathogen Helicobacter pylori can give rise to chronic
gastritis, peptic ulcer, and gastric cancer. All H. pylori strains express the surface-localized …

Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice

Q Liu, X Li, Y Zhang, Z Song, R Li, H Ruan… - Pathogens and …, 2019 - academic.oup.com
As the trend of antibiotic resistance has increased, prevention and treatment of Helicobacter
pylori infection have been challenged by the fact that no vaccines preventing H. pylori …

[HTML][HTML] Vaccine against Helicobacter pylori: Inevitable approach

ATB Abadi - World Journal of Gastroenterology, 2016 - ncbi.nlm.nih.gov
Over three decades have passed since the discovery of Helicobacter pylori (H. pylori), and
yet many questions about its treatment remain unanswered. For example, there is no …

A double mutant heat-labile toxin from Escherichia coli, LT (R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection

L Sjökvist Ottsjö, CF Flach, J Clements… - Infection and …, 2013 - Am Soc Microbiol
Helicobacter pylori infection in the stomach is a common cause of peptic ulcer disease and
is a strong risk factor for the development of gastric adenocarcinoma, yet no effective …

Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

S Raghavan, AK Ostberg, CF Flach, A Ekman… - Infection and …, 2010 - Am Soc Microbiol
Sublingual (SL) immunization has been described as an effective novel way to induce
mucosal immune responses in the respiratory and genital tracts. We examined the potential …

Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses

J Nyström, AM Svennerholm - Vaccine, 2007 - Elsevier
In the present study, we evaluated the capacity of Helicobacter pylori adhesin A (HpaA), a H.
pylori specific colonization factor, to induce therapeutic protection against H. pylori infection …